Infusion pumps get smarter

As bombas do Infusion começam mais espertas

por Keith Loria, Reporter | September 15, 2010

This year, the company launched a new simple infusion pump called the InFuse T-10 Syringe Infuser, designed to be the antithesis of a smart pump to use when a smart pump isn’t warranted.

“This non-programmable pump is ideal for infusions where smart pumps are not necessary,” Schneider says. “This will help health care systems address the constraints that have been placed on them by the recall of the smart pumps by deploying their smart pumps more effectively.”

Training and education based on your needs

Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money

Schneider explains that about 40 percent of all IVs in the hospitals are used to distribute intermittent antibiotics and for these and other less important doses, there’s no need for all the bells and whistles a smart pump offers.

“I don’t want to spend a $3,000 smart pump on that problem, I want to put in a syringe and click and walk away,” he says. “A $150 pump can do that same job and my smart pump money can be used for more critical applications [that provide] nurses with more time to focus on patient care.”

Looking ahead
When industry experts look to the future, they expect infusion pumps to continue advancing in the areas of safety software, wireless systems and integrated management care.

“We will continue to focus on interoperability, that’s really a big push for us,” Hudson says. “We still find a lot of hospitals are looking for that because as their systems are starting to talk to one another, their expectations are that our pumps are able to do the same thing. Another area that will be really important is the area of decision support, about providing the right information at the right time by the bedside.”

LaFortune says that CareFusion will look more globally in the future and see a lot of opportunities to grow around the world.

CareFusion’s activity on the global stage and Baxter making a big move back into the field should provide an infusion of interest to the sector, setting up some interesting developments for the coming years.